This tissue-specific expression pattern aligns with the findings of Wang et al., who reported elevated FZD2 levels in HCC, correlating with advanced tumour stages and poor prognosis (Liu et al., 2021). The gene discussed is FZD2; the disease is hepatocellular carcinoma.